LNP-Based Therapies for Lasting Relief in Monogenic Liver Disorders
Time: 11:30 am
day: Day One
Details:
- LNP and AAV: comparisons in immunogenicity and toxicity and potential for combinatorial approaches
- An overview of immunogenicity and toxicity in metabolic liver disease, striving for enhanced targeting and uptake
- Confronting the challenge of efficiently delivering therapeutic agents to liver cells using LNPs
